![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1708191
¼¼°èÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2025-2034³â)Blood Ketone Meters Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
¼¼°è Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀº 2024³â 4¾ï 1,510¸¸ ´Þ·¯ ±Ô¸ð·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 7.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀÌ·¯ÇÑ ¼ºÀåÀº ´ç´¢º´ À¯º´·ü Áõ°¡, ´ë»ç °Ç° ¸ð´ÏÅ͸µÀÇ Ã¤Å÷ü Áõ°¡, ÄÉÅäÁ¦´Ð ´ÙÀÌ¾îÆ®¿Í Àúź¼öȹ° ´ÙÀÌ¾îÆ®ÀÇ Àα⠱޻ó½Â¿¡ ±âÀÎÇÕ´Ï´Ù. ´õ ¸¹Àº »ç¶÷µéÀÌ °Ç°¿¡ °ü½ÉÀ» °®°í °³ÀÎ ¸ÂÃãÇü °Ç° °ü¸® ¼Ö·ç¼ÇÀ» Ãß±¸ÇÔ¿¡ µû¶ó Ç÷Áß ÄÉÅæ ÃøÁ¤±â¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áý¿¡¼ °£ÆíÇÏ°Ô ÄÉÅæ ³óµµ¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ÇöÀå °Ë»ç(Point-of-Care)´Â ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ¼ÒºñÀÚµéÀÌ ÀÚ½ÅÀÇ °Ç° »óŸ¦ ½±°Ô ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÇ¸é¼ ½ÃÀå ħÅõ°¡ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÄÉÅæ ½Ä´ÜÀ̳ª Àúź¼öȹ° ½Ä´ÜÀÌ Ã¼Áß °ü¸®, ´ç´¢º´ °ü¸®, ½ÅÁø´ë»ç °³¼± µî¿¡ »ç¿ëµÇ´Â °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÄÉÅæ ¸ð´ÏÅ͸µÀº ÀÌ·¯ÇÑ ½Ä´Ü¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖÀ¸¸ç, °³ÀÎÀÌ ¿¡³ÊÁö ¼öÁØÀ» Æò°¡ÇÏ°í ¿µ¾ç °èȹÀ» ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î À¯ÁöÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÚ°¡ ¸ð´ÏÅ͸µ Ãß¼¼´Â °³ÀÎÈµÈ ÇコÄÉ¾î ¼Ö·ç¼Ç ¹× ¿¹¹æÀû °Ç° °ü¸®·ÎÀÇ ±¤¹üÀ§ÇÑ Àüȯ°ú ¸Â¹°·Á ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Ç÷Áß ÄÉÅæ ÃøÁ¤±â´Â Ç÷Áß ÄÉÅæ ¸ð´ÏÅ͸µ, Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ, Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ, ¼Ò¸ðǰ µî Á¦Ç° À¯Çüº°·Î ±¸ºÐµË´Ï´Ù. Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µ ºÐ¾ß´Â ÇÑ ¹øÀÇ °Ë»ç·Î Æ÷µµ´ç°ú ÄÉÅæÀ» ¸ðµÎ ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ´Ù±â´É ±â±âÀÇ °³¹ß·Î 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.4%ÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº º¸´Ù È¿À²ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °Ë»ç¸¦ Á¦°øÇÔÀ¸·Î½á ƯÈ÷ ´ç´¢º´À» °ü¸®ÇÏ´Â »ç¿ëÀÚµéÀÇ ¸ð´ÏÅ͸µ °úÁ¤À» °£¼ÒÈÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ½Ç½Ã°£ ÅëÂû·ÂÀ» Á¦°øÇÔÀ¸·Î½á 1Çü ´ç´¢º´ ȯÀÚÀÇ »ý¸íÀ» À§ÇùÇÒ ¼ö ÀÖ´Â ´ç´¢º´¼º ÄÉÅæ»êÁõ(DKA)À» ¿¹¹æÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ÅëÇÕ ¸ð´ÏÅ͸µ ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Áúº´ °ü¸®¸¦ °£¼ÒÈÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 4¾ï 1,510¸¸ ´Þ·¯ |
¿¹»ó ±Ý¾× | 8¾ï 1,830¸¸ ´Þ·¯ |
CAGR | 7.2% |
¿ëµµ¿¡ µû¶ó Ç÷Áß ÄÉÅæ ÃøÁ¤±â´Â ´ç´¢º´ °ü¸®, üÁß ¹× ½Ä´Ü °ü¸®, ½ºÆ÷Ã÷ °æ±â·Â ¸ð´ÏÅ͸µ, °£Áú Ä¡·á ¹× ±âŸ °Ç° °ü·Ã ¸ñÀûÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´ °ü¸® ºÐ¾ß¿¡¼¸¸ 2024³â 1¾ï 7,600¸¸ ´Þ·¯ÀÇ ¸ÅÃâÀ» ±â·ÏÇß°í, ÀÌ´Â DKA¸¦ ¿¹¹æÇϱâ À§ÇØ ÄÉÅæ ³óµµ¸¦ ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÏ´Ù´Â °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷üµéÀÌ Æ¯È÷ À§Çè¿¡ óÇÑ È¯ÀÚµéÀ» À§ÇÑ Á¤±âÀûÀÎ ÄÉÅæ ¸ð´ÏÅ͸µÀÇ Á߿伺À» °Á¶ÇÔ¿¡ µû¶ó Ç÷Áß ÄÉÅæ ÃøÁ¤±â¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·á¿Í ´õ ³ªÀº Áúº´ °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀº Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¹Ì±¹ÀÇ Ç÷Áß ÄÉÅæ ÃøÁ¤±â ½ÃÀåÀº 2024³â 1¾ï 5,240¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇßÀ¸¸ç, ¹Ì±¹ ³» ´ç´¢º´ ¹× ´ë»ç¼º ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ ¼¼°è ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. üÁß °¨·®°ú ½ÅÁø´ë»ç °Ç° ÁõÁøÀ» À§ÇÑ ÄÉÅæ ´ÙÀÌ¾îÆ®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç÷´ç ¹× ÄÉÅæ ¸ð´ÏÅ͸µÀÌ °áÇÕµÈ ÅëÇÕ ±â±â¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÷´Ü ´Ù±â´É ÇコÄÉ¾î ¼Ö·ç¼ÇÀ¸·ÎÀÇ ±¤¹üÀ§ÇÑ ÀüȯÀ» ¹Ý¿µÇÏ¿© ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. °³ÀÎÈµÈ °Ç° °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹Ì±¹ ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
The Global Blood Ketone Meters Market generated USD 415.1 million in 2024 and is projected to grow at a CAGR of 7.2% between 2025 and 2034. This growth is driven by the increasing prevalence of diabetes, rising adoption of metabolic health monitoring, and the surging popularity of ketogenic and low-carbohydrate diets. As more individuals become health-conscious and seek personalized health management solutions, the demand for blood ketone meters continues to rise. Point-of-care testing, which allows individuals to monitor their ketone levels conveniently at home, has further contributed to market expansion. These advancements make it easier for consumers to track their health, leading to greater market penetration. Additionally, the growing awareness of the benefits of ketogenic and low-carb diets, often used for weight management, diabetes control, and improving metabolic health, is propelling demand. Ketone monitoring is becoming an integral part of these diets, enabling individuals to assess their energy levels and ensure that their nutritional plans remain safe and effective. This trend toward self-monitoring aligns with the broader shift toward personalized healthcare solutions and preventive health management, further bolstering market growth.
Blood ketone meters are segmented by product type, including blood ketone monitoring, blood glucose and ketone monitoring, and consumables. The blood glucose and ketone monitoring segment is expected to grow at a CAGR of 7.4% between 2025 and 2034, driven by the development of multifunctional devices capable of measuring both glucose and ketone levels in a single test. These innovations simplify the monitoring process for users, especially those managing diabetes, by offering more efficient and reliable testing. By providing real-time insights, these devices help prevent diabetic ketoacidosis (DKA), a potentially life-threatening condition for individuals with type 1 diabetes. As technology advances, the growing adoption of integrated monitoring devices is streamlining disease management and enhancing patient outcomes.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $415.1 Million |
Forecast Value | $818.3 Million |
CAGR | 7.2% |
In terms of application, blood ketone meters are widely used for diabetes management, weight and diet control, sports performance monitoring, epilepsy treatment, and other health-related purposes. The diabetes management segment alone generated USD 176 million in 2024, reflecting the critical need for monitoring ketone levels to prevent DKA. As healthcare providers emphasize the importance of regular ketone monitoring, particularly for at-risk patients, the demand for blood ketone meters continues to increase. With a growing focus on preventive care and better disease management, the adoption of these devices is expected to remain strong.
The U.S. blood ketone meters market generated USD 152.4 million in 2024, leading the global market due to the high prevalence of diabetes and metabolic disorders in the country. The growing interest in ketogenic diets for weight loss and improved metabolic health further supports market growth. Additionally, the increasing preference for integrated devices that combine blood glucose and ketone monitoring is driving demand, reflecting a broader shift toward advanced, multifunctional healthcare solutions. As awareness of personalized health management rises, the U.S. market is expected to witness continued growth in the coming years.